Associate Professor, Pediatrics, University of Tennessee Health Science Center College of Medicine
Pediatric Hematology & Oncology
Hiroto Inaba, MB
|
|
Give Review
Hiroto Inaba practices Pediatric Hematology & Oncology. He researched medicine at Wayne State University School of Medicine. Wayne State University School of Medicine has a rank of 63 in research and a 85 in primary care Hiroto Inaba, MB has written publications. He has 29 publications published with PubMed. The lastest paper is: 'NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.'
Publications
- NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.
- Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels.
- Heterogeneous cytogenetic subgroups and outcomes in childhood Acute megakaryoblastic leukemia: a retrospective international study.
- Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood Acute lymphoblastic leukaemia: a prospective study.
- Rapid memory T-Cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies.
- The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin Lymphoma.
- Prognostic factors in children with Acute myeloid leukaemia and excellent response to remission induction therapy.
- Definition of cure in childhood Acute myeloid leukemia.
- A revised definition for cure of childhood Acute lymphoblastic leukemia.
- Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with Acute myeloid leukemia.
- Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive Acute lymphoblastic leukemia.
- Methotrexate-Induced Neurotoxicity and Leukoencephalopathy in Childhood Acute Lymphoblastic Leukemia.
- Emergence of polyclonal FLT3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT3-ITD-positive Acute myeloid leukemia.
- Alternative formulations of sorafenib for use in children.
- Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood Acute myeloid leukemia.
- Crenolanib is active against models of drug-resistant FLT3-ITD-positive Acute myeloid leukemia.
- Acute lymphoblastic leukaemia.
- Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood Acute lymphoblastic leukemia.
- Prognostic features in Acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group S...
- Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for Acute lymphoblastic leukemia.
- Sequential administration of methotrexate and asparaginase in relapsed or refractory pediatric Acute myeloid leukemia.
- Ontogeny and Sorafenib Metabolism.
- Longitudinal Changes in Body Mass and Composition in Survivors of Childhood Hematologic Malignancies After Allogeneic Hematopoietic Stem-Cell Transplantation.
- Childhood Acute myeloid leukaemia.
- Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia.
- Treatment outcome in older patients with childhood Acute myeloid leukemia.
- Effect of body mass index on the outcome of children with Acute myeloid leukemia.
- Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51.
Conditions Treated
- Acute Leukemia
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
- Aetna
- Amerigroup (Wellpoint)
- Assurant Health
- Blue Card PPO
- Network S
- CHAMPVA
- Great West Healthcare-Cigna PPO
- LocalPlus
- Commercial Insurance Company
- Coventry Health Care
- Emblem Health
- Golden Rule
- Choice Care PPO
- Medicaid
- Medicare MCR
- Meritain Health
- MultiPlan PPO
- Tufts Health Plans
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
University of Tennessee -
Wayne State University School of Medicine
Hospital
-
University of Tennessee Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Manhar C. Gandhi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alberto Broniscer, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Rachel C. Brennan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory T. Armstrong, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Judith A. Wilimas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine G. Lam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sima Jeha, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Alberto S. Pappo, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Amar J. Gajjar, MB
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|